Literature DB >> 3962607

The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and by morphometry.

K Tomiwa, C Nolan, J B Cavanagh.   

Abstract

Cisplatin given in doses of 0.5-2 mg to Wistar and to Sprague-Dawley rats produced nucleolar segregation of the dense fibrillar from the granular component in spinal root ganglion cells. The nucleolar segregation, found to the same extent in large and small neurons, was confirmed by specific silver staining and by electron microscopy. After repeated doses of 1 mg or 0.5 mg, up to 40% of affected nucleoli were observed by light microscopy. Focal clearing of the nucleoplasm of nuclei also occurred. Disorganisation of ribosomes was found in more severely intoxicated animals, especially in large light cells with shrinkage of the Nissl substance and apparent increase in neurofilaments, the latter occasionally distending the initial segment of the axon, but never extending further. Hypertrophy of the satellite cells with increase in the perineuronal intercellular spaces, often associated with irregular, scalloped nuclear and cell outlines, suggested that neuron shrinkage had occurred. This was confirmed by morphometry and marked alterations were found in nucleolar-to-nuclear and nucleolar-to-cell diameter ratios, nuclear and cell diameters were also somewhat reduced without change in the nucleus-to-cell ratios. Peripheral sensory nerve degeneration was not seen, and the animals died from non-neural causes. The probable role of these events in the production of sensory neuropathy is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3962607     DOI: 10.1007/bf00688308

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  THE EFFECT OF ACTINOMYCIN D ON THE FINE STRUCTURE OF THE NUCLEOLUS.

Authors:  G I SCHOEFL
Journal:  J Ultrastruct Res       Date:  1964-04

2.  Effects of adriamycin on ultrastructure of nucleoli in the heart and liver cells of the rat.

Authors:  J A Merski; I Daskal; H Busch
Journal:  Cancer Res       Date:  1976-05       Impact factor: 12.701

3.  Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum(II) treatment: a case report.

Authors:  A Kedar; M E Cohen; A I Freeman
Journal:  Cancer Treat Rep       Date:  1978-05

Review 4.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

5.  Interactions between mammalian cell DNA and inorganic platinum compounds. II. Interstrand cross-linking of isolated and cellular DNA by platinum(IV) compounds.

Authors:  J M Pascoe; J J Roberts
Journal:  Biochem Pharmacol       Date:  1974-05-01       Impact factor: 5.858

Review 6.  The ultrastructural visualization of nucleolar and extranucleolar RNA synthesis and distribution.

Authors:  S Fakan; E Puvion
Journal:  Int Rev Cytol       Date:  1980

7.  Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment.

Authors:  D Hadley; H W Herr
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

Review 8.  Drugs five years later. Cisplatin.

Authors:  P J Loehrer; L H Einhorn
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

9.  Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

Authors:  S W Thompson; L E Davis; M Kornfeld; R D Hilgers; J C Standefer
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

10.  Neurotoxic effects of cisplatin therapy.

Authors:  T J Walsh; A W Clark; I M Parhad; W R Green
Journal:  Arch Neurol       Date:  1982-11
View more
  23 in total

Review 1.  Emerging roles of the neuronal nucleolus.

Authors:  Michal Hetman; Maciej Pietrzak
Journal:  Trends Neurosci       Date:  2012-02-02       Impact factor: 13.837

2.  Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration.

Authors:  G Tredici; S Tredici; D Fabbrica; C Minoia; G Cavaletti
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

3.  Sensorimotor neuropathy and cisplatin and adriamycin toxicity.

Authors:  J B Cavanagh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

4.  The axon reaction in spinal ganglion neurons of acrylamide-treated rats.

Authors:  H B Jones; J B Cavanagh
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

5.  Selective cytoplasmic and membrane changes induced by cisplatinum.

Authors:  M A Oberc-Greenwood; B H Smith; C Cooke; C Pepin; P L Kornblith
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

6.  Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement.

Authors:  W Boogerd; W W ten Bokkel Huinink; O Dalesio; W J Hoppenbrouwers; J J van der Sande
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

7.  Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy.

Authors:  M E Helgren; K D Cliffer; K Torrento; C Cavnor; R Curtis; P S DiStefano; S J Wiegand; R M Lindsay
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

8.  Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.

Authors:  Virginia Ip; Johnson J Liu; Julian F B Mercer; Mark J McKeage
Journal:  Mol Pain       Date:  2010-09-13       Impact factor: 3.395

9.  Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione.

Authors:  G Bogliun; L Marzorati; G Cavaletti; L Frattola
Journal:  Ital J Neurol Sci       Date:  1992-11

10.  Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity.

Authors:  S M F Jamieson; J Liu; T Hsu; B C Baguley; M J McKeage
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.